ArticleFrontiers in surgery2022

No obvious advantage of hyperthermic intraperitoneal chemotherapy after interval debulking surgery in the treatment of advanced ovarian cancer: A retrospective study.

Mengmeng Lyu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.